Just at two sites, Mt Sinai and the Cleveland Clinic undertake approximately 1200 TAVR operations per year. If both are part of our trial, and with continuing use before FDA final approval, these two alone represent $30 million in potential revenue pa, before FDA approval (said twice for emphasis).
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.03 |
Change
0.010(0.17%) |
Mkt cap ! $93.45M | |||
| Open | High | Low | Value | Volume |
| $6.00 | $6.16 | $5.80 | $52.24K | 8.792K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 857 | $5.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.45 | 1000 | 1 |
View Market Depth
| Last trade - 15.36pm 20/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |